Annual report
4937.TEDINET S100SIBJ
Period2022-10-01 → 2023-09-30
Filed2023-12-21
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed
Key figures · 115
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.7bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥2.7bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥278m | 2022-10-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | −¥40m | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥288m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥22m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥34m | 2022-10-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥22m | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥28m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥57m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥28m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥57m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2022-09-30 | Cons. | Assets |
| Total liabilities | ¥809m | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥821m | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥773m | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥743m | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥801m | at 2021-09-30d | Cons. | Net assets |
| Cash and deposits | ¥1.3bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥906m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥906m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥456m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥169m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥49m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥176m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥8m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥129m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥9.43 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-19.04 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.32 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥256.73 | at 2023-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥246.98 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 48.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 3.7% | 2022-10-01 → 2023-09-30 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 50 | at 2023-09-30 | Cons. | Number of employees |
| Employees | 44 | at 2022-09-30 | Cons. | Number of employees |
| Revenue | ¥1.7bn | 2022-10-01 → 2023-09-30 | Standalone | Net sales |
| Revenue | ¥2.7bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥4.7bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.5bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.4bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥252m | 2022-10-01 → 2023-09-30 | Standalone | Operating income |
| Operating income | −¥40m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Ordinary income | ¥275m | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥21m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥141m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥109m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥794m | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥34m | 2022-10-01 → 2023-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥21m | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Net income | ¥32m | 2022-10-01 → 2023-09-30 | Standalone | Profit loss |
| Net income | −¥57m | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥116m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥99m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | −¥795m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.6bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥1.6bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥1.9bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.2bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.0bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥802m | at 2023-09-30 | Standalone | Liabilities |
| Total liabilities | ¥820m | at 2022-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥777m | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥743m | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥801m | at 2021-09-30d | Standalone | Net assets |
| Net assets / equity | ¥161m | at 2020-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥63m | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2023-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥905m | at 2022-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.0bn | at 2021-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥474m | at 2020-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥399m | at 2019-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥128m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥88m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥986m | 2018-10-01 → 2019-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥6m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥2m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥20m | 2018-10-01 → 2019-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥703m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥16m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥829m | 2018-10-01 → 2019-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥10.57 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.95 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.61 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.45 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-324.74 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥10.44 | 2022-10-01 → 2023-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥40.9 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥257.96 | at 2023-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥247.07 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥266.72 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥59.61 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥23.16 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 49.2% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.5% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 13.7% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 6.3% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.2% | 2022-10-01 → 2023-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.1% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 88.1% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,010,278 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,006,178 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,001,178 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,353,175 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 270,635 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 50 | at 2023-09-30 | Standalone | Number of employees |
| Employees | 44 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 72 | at 2021-09-30d | Standalone | Number of employees |
| Employees | 59 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 55 | at 2019-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2022-10-01 → 2023-09-30 | ¥777,000 |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-09-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-09-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-09-30 | −¥353m |
| Direct To Consumer Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥5m |
| Direct To Consumer Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥1.6bn |
| Direct To Consumer Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥1.6bn |
| Direct To Consumer Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥1m |
| Direct To Consumer Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥679m |
| Medical Supportreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥167m |
| Medical Supportreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥167m |
| Medical Supportreportable segment | segment profit | 2022-10-01 → 2023-09-30 | −¥48m |
| —segment total | depreciation | 2022-10-01 → 2023-09-30 | ¥5m |
| —segment total | revenue | 2022-10-01 → 2023-09-30 | ¥1.7bn |
| —segment total | revenue external | 2022-10-01 → 2023-09-30 | ¥1.7bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥1m |
| —segment total | segment profit | 2022-10-01 → 2023-09-30 | ¥631m |
| Reconciling Itemsreconciling | depreciation | 2021-10-01 → 2022-09-30 | ¥1m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥319m |
| Direct To Consumer Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥5m |
| Direct To Consumer Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥2.5bn |
| Direct To Consumer Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥2.5bn |
| Direct To Consumer Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥123m |
| Medical Supportreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥200m |
| Medical Supportreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥200m |
| Medical Supportreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥156m |
| —segment total | depreciation | 2021-10-01 → 2022-09-30 | ¥5m |
| —segment total | revenue | 2021-10-01 → 2022-09-30 | ¥2.7bn |
| —segment total | revenue external | 2021-10-01 → 2022-09-30 | ¥2.7bn |
| —segment total | segment profit | 2021-10-01 → 2022-09-30 | ¥279m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,180
| Item | Context | Value | Unit |
|---|---|---|---|
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | -985906000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 88365000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | -128483000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | -20079000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 2314000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | -6377000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 829099000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | -15814000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 703488000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 399199000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 474065000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 1042693000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant_NonConsolidatedMember | － | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant_NonConsolidatedMember | － | JPY |
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 55 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 59 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 72 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 44 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 50 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.649 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.838 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 0.617 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 0.647 | |
| Number of employees | CurrentYearInstant | 50 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 50 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 37.4 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 4.9 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 4720000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3010278 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3010278 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 3010278 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 3010278 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 3 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 14 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 19 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 23 of 23 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |